GAD1 and diabetes mellitus: One patient who developed diabetes mellitus at the age of 15 years tested negative for genomic markers of maturity-onset diabetes of the young (MODY) and GAD antibody and consequently received metformin; another patient developed IGT at the age of 24 years.